The European Commission has announced its Europe's Beating Cancer Plan which sets out a new EU approach to cancer prevention, treatment and care.
Hugh Bettesworth, CEO, Mirada Medical, explores how AI autocontouring technology can help tackle the cancer care backlog as a result of the COVID-19 pandemic.
Black women face higher mortality rates and recurrence of breast cancer, according to researchers from University of Illinois Chicago.
Scientists have identified two drugs that are effective in acute myeloid leukemia (AML) treatment when combined.
A new study revealing how ovarian cancer cells adapt to their environment to aid tumour growth brings researchers closer to developing targeted treatments.
Michelle Vickers, CEO of the Head and Neck Cancer Foundation tells us what we need to know about head and neck cancer treatment, including comment on driving surgical-technological development.
Zisis Kozlakidis, International Agency for Research on Cancer and Chite Asirwa, International Cancer Institute, walk us through the cancer challenges in Sub-Saharan Africa today.
Leading pancreatic cancer experts Professor Matthias Löhr and Professor Monique van Leerdam of United European Gastroenterology’s (UEG) Public Affairs Committee discuss the importance of early diagnosis and the latest developments in treatment for pancreatic cancer.
Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.
Researchers from the University of Western Australia have found that the venom of honeybees can destroy aggressive breast cancer cells in a lab setting.
Scientists at St. Jude Children's Research Hospital have discovered that hearing loss in childhood cancer survivors is associated with an increased risk for neurocognitive deficits.
Dr Frank Wuest, Professor at Department of Oncology - University of Alberta, sheds light on the imaging biomarkers and the Alberta Radiopharmaceutical Collaboration in this special oncology focus.
Here, the International Agency for Research on Cancer and other experts provide an in-depth analysis of cancer, the second leading cause of death after cardiovascular diseases plus the role of technology and innovation in the field.
Prof Nicolo Riggi and Prof Ivan Stamenkovic from the University of Lausanne share their thoughts on the pathogenesis of paediatric cancers.
Here, Jaime F. Modiano examines the similarities of cancer in dogs and humans, exploring the idea of a common origin.
Monique van Leerdam, leading colorectal cancer expert and Member of the United European Gastroenterology Public Affairs Committee, discusses what action can be taken to reduce the heavy burden of colorectal cancer across Europe.
Peter Goodhand and Angela Page from Global Alliance for Genomics and Health, explain their thoughts on enabling a global learning health system through genomic standards.
Here, Andrea Seale CEO of the Canadian Cancer Society, discusses the recently elected government’s commitments to support Canadians with cancer.
Here, Professor Stuart Taylor at University College London (UCL), discusses the possibilities of whole body MRI in cancer staging.
The National Cancer Research Institute (NCRI) released figures today (4 February) showing that NCRI funding has reached £700 million for the first time.